— Know what they know.
Not Investment Advice

VRPX OTC

Virpax Pharmaceuticals, Inc.
1W: +0.0% 1M: +11000.0% 3M: +0.0% YTD: +0.9% 1Y: -55.6% 3Y: -100.0% 5Y: -100.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $13792 mcap · 1M float · 0.043% daily turnover · Short 43% of daily vol

Balance Sheet Trends

Total Assets
$1.6B +16056.6% ▲
5Y CAGR: +702.6%
Total Liabilities
$2.5B +31994.7% ▲
5Y CAGR: +288.8%
Shareholders Equity
-$914M -47339.3% ▼
Cash & Investments
$1.5B +16451.5% ▲
5Y CAGR: +717.1%
Total Debt
$0 +0.0% ▲
Net Debt
-$2M +83.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$55K$37M$19M$9M$2M
Short-Term Investments$0$0$0$0$1.5B
Cash & ST Investments$55K$37M$19M$9M$1.5B
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$535$3M$496K$283K$43M
Total Current Assets$73K$40M$20M$10M$1.6B
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$392K$0$0$0$0
Total Non-Current Assets$392K$0$0$0$0
Total Assets$465K$40M$20M$10M$1.6B
— Liabilities —
Accounts Payable$22K$20K$38K$18K$0
Short-Term Debt$544K$0$0$0$0
Deferred Revenue-$1M$0$0$0$0
Other Current Liabilities$1M$0$2M$6M$2.5B
Total Current Liabilities$4M$2M$3M$8M$2.5B
Long-Term Debt$1M$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$1M$0$1K$0$0
Total Liabilities$5M$2M$3M$8M$2.5B
— Equity —
Common Stock$31$117$117$12$149
Retained Earnings-$11M-$23M-$44M-$60M-$71.6B
Accumulated OCI$0-$0-$0-$0$0
Total Stockholders Equity-$4M$37M$17M$2M-$914M
Total Liabilities & Equity$465K$40M$20M$10M$1.6B
— Key Metrics —
Total Debt$2M$0$0$0$0
Net Debt$2M-$37M-$19M-$9M-$2M
Total Investments$0$0$0$0$1.5B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms